Delta-like 1 participates in the specification of ventral midbrain progenitor derived dopaminergic neurons

Journal of Neurochemistry

Volumn 104, Issue 4, 2008, Pages 1101-1115

  Bauer, Matthias ^a,b,c   Szulc, Jolanta ^c   Meyer, Morten ^d   Jensen, Charlotte Harken ^d   Terki, Toufik Abbas ^c   Meixner, Andrea ^a,b   Kinkl, Norbert ^a,b   Gasser, Thomas ^e   Aebischer, Patrick ^c   Ueffing, Marius ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c EPFL   (Switzerland)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Delta like 1; Differentiation; Dopaminergic precursors; Lentiviral vectors; shRNA; Ventral midbrain progenitors

Indexed keywords

CELL MARKER; DELTA LIKE 1 PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

EID: 38549168969     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05037.x     Document Type: Article

References (46)

1. Abbas-Terki T., Blanco-Bose W., Deglon N., Pralong W. Aebischer P. (2002) Lentiviral-mediated RNA interference. Hum. Gene Ther. 13, 2197 2201.
2. Alvarez V. A., Ridenour D. A. Sabatini B. L. (2006) Retraction of synapses and dendritic spines induced by off-target effects of RNA interference. J. Neurosci. 26, 7820 7825.
3. Asbreuk C. H., Vogelaar C. F., Hellemons A., Smidt M. P. Burbach J. P. (2002) CNS expression pattern of Lmx1b and coexpression with ptx genes suggest functional cooperativity in the development of forebrain motor control systems. Mol. Cell. Neurosci. 21, 410 420.
4. Baladron V., Ruiz-Hidalgo M. J., Nueda M. L., Diaz-Guerra M. J., Garcia-Ramirez J. J., Bonvini E., Gubina E. Laborda J. (2005) dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp. Cell Res. 303, 343 359.
5. Bauer M., Meyer M., Grimm L., Meitinger T., Zimmer J., Gasser T., Ueffing M. Widmer H. R. (2000) Nonviral glial cell-derived neurotrophic factor gene transfer enhances survival of cultured dopaminergic neurons and improves their function after transplantation in a rat model of Parkinson's disease. Hum. Gene Ther. 11, 1529 1541.
6. Bauer M., Suppmann S., Meyer M., Hesslinger C., Gasser T., Widmer H. R. Ueffing M. (2002) Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones. J. Neurochem. 82, 1300 1310.
7. Bridge A. J., Pebernard S., Ducraux A., Nicoulaz A. L. Iggo R. (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263 264.
8. Brummelkamp T. R., Bernards R. Agami R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550 553.
9. Castelo-Branco G., Wagner J., Rodriguez F. J., Kele J., Sousa K., Rawal N., Pasolli H. A., Fuchs E., Kitajewski J. Arenas E. (2003) Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc. Natl Acad. Sci. USA 100, 12747 12752.
10. Castelo-Branco G., Rawal N. Arenas E. (2004) GSK-3b inhibition/b-catenin stabilization in ventral midbrain precursors increases differentiation in to dopamine neurons. J. Cell Sci. 117, 5731 5737.
11. Castelo-Branco G., Sousa K. M., Bryja V., Pinto L., Wagner J. Arenas E. (2006) Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion. Mol. Cell. Neurosci. 31, 251 262.
12. Christophersen N. S., Gronborg M., Petersen T. N., Fjord-Larsen L., Jorgensen J. R., Juliusson B., Blom N., Rosenblad C. Brundin P. (2007) Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation. Exp. Neurol. 2004, 791 801.
13. Editorial in Nature Cell Biology (2003) Wither RNAi? Nat. Cell Biol. 5, 489 490.
14. Garces C., Ruiz-Hidalgo M. J., Bonvini E., Goldstein J. Laborda J. (1999) Adipocyte differentiation is modulated by secreted delta-like (dlk) variants and requires the expression of membrane-associated dlk. Differentiation 64, 103 114.
15. Helman L. J., Thiele C. J., Linehan W. M., Nelkin B. D., Baylin S. B. Israel M. A. (1987) Molecular markers of neuroendocrine development and evidence of environmental regulation. Proc. Natl Acad. Sci. USA 84, 2336 2339.
16. Jensen P., Bauer M., Jensen C. H., Widmer H. R., Gramsberg J. B., Blaabjerg M., Zimmer J. Meyer M. (2007) Expansion and characterization of ventral mesencephalic precursor cells: effect of mitogens and investigation of FA1 as a potential dopaminergic marker. J. Neurosci. Res. 85, 1884 1893.
17. Jensen C. H., Teisner B., Hojrup P., Rasmussen H. B., Madsen O. D., Nielsen B. Skjodt K. (1993) Studies on the isolation, structural analysis and tissue localization of fetal antigen 1 and its relation to a human adrenal-specific cDNA, pG2. Hum. Reprod. 8, 635 641.
18. Jensen C. H., Meyer M., Schroder H. D., Kliem A., Zimmer J. Teisner B. (2001) Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk. Neuroreport 12, 3959 3963.
19. Kaneta M., Osawa M., Sudo K., Nakauchi H., Farr A. G. Takahama Y. (2000) A role for pref-1 and HES-1 in thymocyte development. J. Immunol. 164, 256 264.
20. Kawakami T., Chano T., Minami K., Okabe H., Okada Y. Okamoto K. (2006) Imprinted Dlk1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Hum. Mol. Genet. 15, 821 830.
21. Laborda J., Sausville E. A., Hoffman T. Notario V. (1993) dlk, a putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line. J. Biol. Chem. 268, 3817 3820.
22. Laborda J. (2000) The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol. Histopathol. 15, 119 129.
23. Lee K., Villena J. A., Moon Y. S., Kim K. H., Lee S., Kang C. Sul H. S. (2003) Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J. Clin. Invest. 111, 453 461.
24. Li L., Forman S. J. Bhatia R. (2005) Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation. Oncogene 24, 4472 4476.
25. Lindsell C. E., Boulter J., diSibio G., Gossler A. Weinmaster G. (1996) Expression patterns of Jagged, Delta1, Notch1, Notch2, and Notch3 genes identify ligand-receptor pairs that may function in neural development. Mol. Cell. Neurosci. 8, 14 27.
26. Lo Bianco C., Ridet J. L., Schneider B. L., Deglon N. Aebischer P. (2002) alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl Acad. Sci. USA 99, 10813 10818.
27. Nueda M. L., Baladron V., Sanchez-Solana B., Ballesteros M. A. Laborda J. (2007) The EGF-like protein dlk1 inhibits notch signaling and potentiates adipogenesis of mesenchymal cells. J. Mol. Biol. 367, 1281 1293.
28. Ohno N., Izawa A., Hattori M., Kageyama R. Sudo T. (2001) dlk inhibits stem cell factor-induced colony formation of murine hematopoietic progenitors: Hes-1-independent effect. Stem Cells 19, 71 79.
29. Prakash N. Wurst W. (2006a) Genetic networks controlling the development of midbrain dopaminergic neurons. J. Physiol. 575, 403 410.
30. Prakash N. Wurst W. (2006b) Development of dopaminergic neurons in the mammalian brain. Cell. Mol. Life Sci. 63, 187 206.
31. Sakajiri S., O'kelly J., Yin D. et al. (2005) Dlk1 in normal and abnormal hematopoiesis. Leukemia 19, 1404 1410.
32. Simon P. (2003) Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics 19, 1439 1440.
33. Smas C. M. Sul H. S. (1993) Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 73, 725 734.
34. Smas C. M., Green D. Sul H. S. (1994) Structural characterization and alternate splicing of the gene encoding the preadipocyte EGF-like protein pref-1. Biochemistry 33, 9257 9265.
35. Smas C. M., Chen L. Sul H. S. (1997) Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation. Mol. Cell. Biol. 17, 977 988.
36. Smas C. M., Chen L., Zhao L., Latasa M. J. Sul H. S. (1999) Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation. J. Biol. Chem. 274, 12632 12641.
37. Smidt M. P., Asbreuk C. H., Cox J. J., Chen H., Johnson R. L. Burbach J. P. (2000) A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 3, 337 341.
38. Smidt M. P., Smits S. M. Burbach J. P. (2003) Molecular mechanisms underlying midbrain dopamine neuron development and function. Eur. J. Pharmacol. 480, 75 88.
39. Smidt M. P., Smits M. S., Bouwmeester H., Hamers F. P. T., van der Linden A. J. A., Hellemons A.-J. C. G. M., Graw J. Burbach J. P. H. (2004) Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 131, 1145 1155.
40. Smits S. M., Ponnio T., Conneely O. M., Burbach J. P. Smidt M. P. (2003) Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur. J. Neurosci. 18, 1731 1738.
41. Tanimizu N., Nishikawa M., Saito H., Tsujimura T. Miyajima A. (2003) Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J. Cell Sci. 116, 1775 1786.
42. Wallen A., Zetterström R. H., Solomin L., Arvidsson M., Olson L. Perlmann T. (1999) Fate of mesencephalic AHD2-expressing dopamine progenitor cells in Nurr1 mutant mice. Exp. Cell Res. 253, 737 746.
43. Wallen A., Castro D. S., Zetterstrom R. H., Karlen M., Olson L., Ericson J. Perlmann T. (2001) Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem. Mol. Cell. Neurosci. 18, 649 663.
44. Wallen A. Perlmann T. (2003) Transcriptional control of dopamine neuron development. Ann. NY Acad. Sci. 991, 48 60.
45. Wiznerowicz M. Trono D. (2003) Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957 8961.
46. Yin D., Xie D., Sakajiri S., Miller C. W., Zhu H., Popoviciu M. L., Black K. L. Koeffler H. P. (2006) Dlk1: increased expression in gliomas and associated with oncogenic activities. Oncogene 25, 1852 1861.